by Blood Advances
New research findings provide additional insight into the complexities of care in older patients who have undergone blood or marrow transplants. There is limited knowledge on the subject, but...
by Bone Marrow Transplantation
Although little is known about deletion of the long arm of chromosome 20 [del(20q)], a donor-derived cytogenetic abnormality that can occur after allogeneic hematopoietic cell transplantation...
by Healio
The Joint Basic and Translational Scientific Meeting, cohosted by the American Society for Transplantation and Cellular Therapy and European Bone Marrow Transplantation Society, will be held May...
by ASTCT Talks
In this episode of ASTCT Talks, host Corey Cutler, MD of Dana-Farber Cancer Institute and Harvard University sits down with Nosha Farhadfar, MD, medical director of research for Sarah Cannon...
by Neuro-Oncology
Chimeric antigen receptor (CAR) T cells targeting B7-H3 show promise in treating diffuse intrinsic pontine glioma (DIPG), but researchers suspect the true potential of this approach will only be...
by Transplantation and Cellular Therapy
While an immunosuppressive tumor microenvironment (TME) limits the efficacy of chimeric antigen receptor (CAR) immunotherapy in solid tumors, lab experiments suggest the treatment could advance by...